Optimum modification for the highest cytotoxicity of cationized ribonuclease

Journal of Biochemistry

Volumn 132, Issue 2, 2002, Pages 223-228

  Futami, Junichiro ^a   Nukui, Emiko ^a   Maeda, Takashi ^a   Kosaka, Megumi ^a   Tada, Hiroko ^a   Seno, Masaharu ^a   Yamada, Hidenori ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cationization; Cytotoxicity; Protein transduction; Ribonuclease

Indexed keywords

CARBOXYL GROUP; ETHYLENEDIAMINE; RIBONUCLEASE; RIBONUCLEASE A; CATION; PANCREATIC RIBONUCLEASE;

ADSORPTION; ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CATION TRANSPORT; CELL SURFACE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; CYTOTOXICITY; ELECTRICITY; ENZYME MODIFICATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PROTEIN FUNCTION; REACTION OPTIMIZATION; SIGNAL TRANSDUCTION; TECHNOLOGY; ANIMAL; CATTLE; CELL LINE; CELL SURVIVAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

ANIMALS; CATIONS; CATTLE; CELL LINE; CELL SURVIVAL; HUMANS; MICE; PROTEIN TRANSPORT; RIBONUCLEASE, PANCREATIC;

EID: 0036684790     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a003214     Document Type: Article

References (56)

1. Antitumor RNases
2. Natural and engineered cytotoxic ribonucleases: Therapeutic potential
3. Cancer chemotherapyribonucleases to the rescue
4. Ribonucleases and their antitumor activity
5. Ribonuclease A
6. In vitro studies on selective inhibition of tumor cell growth by seminal ribonuclease
7. Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases
8. Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily
9. Biochemistry of frog ribonucleases
10. pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells
11. Cleavage of oligoribonucleotides by the 2′,5′-oligoadenylate-dependent ribonuclease L
12. 2-5A-dependent RNase L: A regulated endoribonuclease in the interferon system
13. Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins
14. Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo
15. Epidermal growth factor receptor-dependent cytotoxicity for human squamous carcinoma cell lines of a conjugate composed of human EGF and RNase 1
16. Molecular targeting for epidermal growth factor receptor expressed on breast cancer cells by human fusion protein
17. Human pancreatic RNase1-human epidermal growth factor fusion: An entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas
18. Epidermal growth factor receptor-dependent cytotoxic effect of anti-EGFR antibody-ribonuclease conjugate on human cancer cells
19. Inhibition of cell growth by a fused protein of human ribonuclease 1 and human basic fibroblast growth factor
20. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction
21. Targeting activated lymphocytes with an entirely human immunotoxin analogue: Human pancreatic RNasel-human IL-2 fusion
22. Preparation of potent cytotoxic ribonucleases by cationization: Enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups
23. Effect of modification of the carboxyl groups of the sialic acid binding lectin from bull-frog (Rana catesbeiana) oocyte on anti-tumor activity
24. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration
25. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
26. In vivo protein transduction: Delivery of a biologically active protein into the mouse
27. Protein therapy-delivery guaranteed
28. Protein transduction: Unrestricted delivery into all cells?
29. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo
30. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
31. Selective modification of aspartic acid-101 in lysozyme by carbodiimide reaction
32. A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3′ UTR of unusual length and structure
33. Convenient and efficient in vitro folding of disulfide-containing globular protein from crude bacterial inclusion bodies
34. Stabilization of human RNase 1 by introduction of a disulfide bond between residues 4 and 118
35. A human cell line from a pleural effusion derived from a breast carcinoma
36. Ribonucleolytic activity of angiogenin: Essential histidine, lysine, and arginine residues
37. Ribonuclease inhibitor from human placenta. Purification and properties
38. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor
39. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity
40. Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans
41. Ribonuclease A variants with potent cytotoxic activity
42. Ribonuclease inhibitor
43. Key extracellular and intracellular steps in the antitumor action of seminal ribonuclease
44. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A
45. Refinement of the structure of bovine seminal ribonuclease
46. A study of the intracellular routing of cytotoxic ribonudeases
47. Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins
48. Conformational stability is a determinant of ribonuclease A cytotoxicity
49. Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport
50. Cationization of protein antigens. IV. Increased antigen uptake by antigen-presenting cells
51. Blood-brain barrier transport of cationized immunoglobulin G: Enhanced delivery compared to native protein
52. Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate
53. Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of anti-rev antibodies after cationization
54. Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization
55. Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein
56. Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat